Mifepristone Pain Relief Medications Side Effects Medication Safety GIP/GLP-1 Agonists Adherence Sodium Valproate GLP-1 Analogues Supply Chain Supply Chain Issues Pharmacology Pharmaceuticals Abortion Medications Abortion Drugs Diabetes Treatment Aspirin HRT Forms Prescription Practices High-risk Medicines Overdose Blood Thinners Children's Health Insulin Inhalers FDA Regulations GLP-1 Medications Drug Safety Alternatives Drug Delivery GLP-1 Agonists Abortion Pill Prescription Drugs Ozempic Banned Substances
The National Pharmacy Association highlights safety risks, counterfeit concerns, and calls for regulatory reforms as hay fever cases spike across the UK.